Nuclius Remedies Private Limited - Company Profile

It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2024.
2024 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Nuclius Remedies Private Limited

Nuclius Remedies Private Limited, a active private limited company, was established on 12 August 2024 in Mumbai, Maharashtra, India. it holds CIN: U47721MH2024PTC430542. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Vandana Lotan Jadhav (Director), Rajani Sanju Gangurde (Director), Vinay Vasant Yewalekar (Director). Its latest AGM occurred on 06 May 2025, with the balance sheet filed on 31 March 2025. It is based at 51,Floor-2,15,B D D Chawl,Sewree, X Road,Sewree Railway Station, Mumbai, Maharashtra, 400015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U47721MH2024PTC430542

  • Registration Number

    430542

  • Incorporation Date

    12 August 2024

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 6 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Nuclius Remedies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nuclius Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nuclius Remedies Private Limited?
Current Directors
Name Designation Appointment Date Status
Vandana Lotan Jadhav Director 12 Aug 2024 Current
Rajani Sanju Gangurde Director 12 Aug 2024 Current
Vinay Vasant Yewalekar Director 12 Aug 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nuclius Remedies.

Enhance accessibility to Nuclius Remedies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Nuclius Remedies revenue growth over time
Nuclius Remedies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nuclius Remedies?

Unlock access to Nuclius Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nuclius Remedies?

Unlock and access historical data on people associated with Nuclius Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nuclius Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuclius Remedies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nuclius Remedies
Recent Activity within the Organization
  • Annual General Meeting

    The activity Nuclius Remedies Private Limited last Annual general meeting of members was held on 06 May 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Nuclius Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    Vandana Lotan Jadhav was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Rajani Sanju Gangurde was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 1 year 6 months . was documented.

  • Director Appointment

    The activity Vinay Vasant Yewalekar was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 1 year 6 months . was completed.

  • Company Incorporation

    Progress on Nuclius Remedies Private Limited was registered on 12 Aug 2024 with Roc Mumbai & aged 1 year 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nuclius Remedies Private Limited?

The CIN of Nuclius Remedies Private Limited is U47721MH2024PTC430542.

Where is Nuclius Remedies Private Limited headquartered?

Nuclius Remedies Private Limited is headquartered at 51,Floor-2,15,B D D Chawl,Sewree, X Road,Sewree Railway Station, Mumbai, Maharashtra, 400015.

When was Nuclius Remedies Private Limited incorporated?

Nuclius Remedies Private Limited was incorporated on 12 August 2024.

Who are the current directors of Nuclius Remedies Private Limited?

The current directors of Nuclius Remedies Private Limited are

Is Nuclius Remedies Private Limited a listed company?

Nuclius Remedies Private Limited is unlisted.

What is the capital structure of Nuclius Remedies Private Limited?

The authorized capital of Nuclius Remedies Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available